erlotinib hydrochloride has been researched along with Anemia, Hemolytic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mennecier, B; Quoix, A; Sakhri, L | 1 |
1 review(s) available for erlotinib hydrochloride and Anemia, Hemolytic
| Article | Year |
|---|---|
[Hemolytic anemia under erlotinib treatment].
Topics: Aged, 80 and over; Anemia, Hemolytic; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines | 2013 |